NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Clinical trials for NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER explained in plain language.
Never miss a new study
Get alerted when new NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER trials appear
Sign up with your email to follow new studies for NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Milder chemo before stem cell transplant may help treat non-cancer blood disorders with fewer side effects
Disease control Recruiting nowThis study tests a less intense chemotherapy combination (treosulfan, fludarabine, and thiotepa) given before a donor stem cell transplant for people with non-cancerous blood or immune system disorders. The goal is to see if this gentler regimen can still allow the donor cells to…
Matched conditions: NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
Can we predict blood cancer after ovarian cancer treatment?
Knowledge-focused Recruiting nowThis study follows 2,000 people with ovarian or other solid cancers to understand why some later develop blood cancers. Researchers will look for genetic changes and other risk factors. The goal is to better predict and prevent these secondary cancers.
Matched conditions: NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:09 UTC